Somaxon Pharmaceuticals is a specialty pharmaceutical company currently focused on the central nervous system therapeutic area. The company’s efforts are targeted at the in-licensing, development, and commercialization of proprietary branded products and late-stage product candidates to treat significant medical conditions where there is an unmet medical need or significant patient dissatisfaction. Somaxon’s product Silenor is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance and is available by prescription in the U.S. For more information, visit the company’s Web site at www.somaxon.com

ROTH Capital Partners is a relationship-driven investment bank that primarily focuses on connecting small-cap publicly traded companies with institutional investors. This year’s annual ROTH conference will take place at The Ritz Carlton located in Dana Point, CA, on March 11-14. Bringing together executives from more than 400 growth companies, the 24th Annual ROTH Conference is one of the largest of its kind in the U.S. For more information on ROTH Capital Partners, visit www.roth.com

Let us hear your thoughts below: